STAASTAAR SURGICAL CO

Nasdaq staar.com


$ 46.94 $ 0.07 (0.15 %)    

Friday, 26-Apr-2024 15:59:49 EDT
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 46.96
$ 47.16
$ 0.00 x 0
$ 0.00 x 0
$ 46.45 - $ 47.94
$ 26.66 - $ 73.13
335,626
na
2.32B
$ 1.25
$ 108.73
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-27-2024 12-29-2023 10-K
2 11-06-2023 09-29-2023 10-Q
3 08-02-2023 06-30-2023 10-Q
4 05-03-2023 03-31-2023 10-Q
5 02-23-2023 12-30-2022 10-K
6 11-02-2022 09-30-2022 10-Q
7 08-10-2022 07-01-2022 10-Q
8 05-04-2022 04-01-2022 10-Q
9 02-23-2022 12-31-2021 10-K
10 11-03-2021 10-01-2021 10-Q
11 08-04-2021 07-02-2021 10-Q
12 05-05-2021 04-02-2021 10-Q
13 02-24-2021 01-01-2021 10-K
14 11-04-2020 10-02-2020 10-Q
15 08-05-2020 07-03-2020 10-Q
16 05-06-2020 04-03-2020 10-Q
17 02-26-2020 01-03-2020 10-K
18 10-30-2019 09-27-2019 10-Q
19 07-31-2019 06-28-2019 10-Q
20 05-01-2019 03-29-2019 10-Q
21 02-21-2019 12-28-2018 10-K
22 10-31-2018 09-28-2018 10-Q
23 08-01-2018 06-29-2018 10-Q
24 05-02-2018 03-30-2018 10-Q
25 02-28-2018 12-29-2017 10-K
26 11-08-2017 09-29-2017 10-Q
27 08-02-2017 06-30-2017 10-Q
28 05-03-2017 03-31-2017 10-Q
29 03-02-2017 12-30-2016 10-K
30 11-03-2016 09-30-2016 10-Q
31 08-03-2016 07-01-2016 10-Q
32 05-11-2016 04-01-2016 10-Q
33 03-11-2016 01-01-2016 10-K
34 11-04-2015 10-02-2015 10-Q
35 08-07-2015 07-03-2015 10-Q
36 05-12-2015 04-03-2015 10-Q
37 03-13-2015 01-02-2015 10-K
38 11-07-2014 10-03-2014 10-Q
39 07-31-2014 07-04-2014 10-Q
40 05-13-2014 04-04-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 apple-to-210-here-are-10-top-analyst-forecasts-for-thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

 mizuho-maintains-buy-on-staar-surgical-raises-price-target-to-53

Mizuho analyst Anthony Petrone maintains Staar Surgical (NASDAQ:STAA) with a Buy and raises the price target from $45 to $53.

 canaccord-genuity-maintains-hold-on-staar-surgical-raises-price-target-to-46

Canaccord Genuity analyst Jon Young maintains Staar Surgical (NASDAQ:STAA) with a Hold and raises the price target from $32 ...

 eye-lens-maker-staar-surgical-expects-q1-sales-to-beat-consensus

STAAR Surgical reports Q1 2024 net sales surpassing $77 million, with U.S. ICL sales hitting $5 million, the highest since FDA ...

 why-staar-surgical-shares-are-trading-higher-by-around-13-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of STAAR Surgical Company (NASDAQ: STAA) rose sharply during Thursday’s session after the company issued strong prelimi...

 needham-reiterates-hold-on-staar-surgical

Needham analyst David Saxon reiterates Staar Surgical (NASDAQ:STAA) with a Hold.

Core News & Articles
Market-Moving News for April 4th
04/04/2024 12:33:04

TVGN: 101% | Tevogen Bio Appoints Tapan V Shah as Head of Investor Relations and Corporate Development CADL: 62% | Candel Ther...

 staar-surgical-reports-preliminary-net-sales-for-q1-to-be-in-excess-of-77m-est-72134m-now-expects-fy24-net-sales-can-be-at-higher-end-of-prior-outlook-range-of-335m-340m-est-337208m

U.S. ICL sales expected to be $5 million for the quarter. This represents the Company's highest quarterly ICL sales in the ...

 stifel-maintains-buy-on-staar-surgical-maintains-50-price-target

Stifel analyst Thomas Stephan maintains Staar Surgical (NASDAQ:STAA) with a Buy and maintains $50 price target.

 why-mesoblast-shares-are-trading-higher-by-13-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an ...

 netflix-to-rally-around-20-here-are-10-top-analyst-forecasts-for-monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

 stifel-upgrades-staar-surgical-to-buy-raises-price-target-to-50

Stifel analyst Thomas Stephan upgrades Staar Surgical (NASDAQ:STAA) from Hold to Buy and raises the price target from $30 to...

 mizuho-maintains-buy-on-staar-surgical-lowers-price-target-to-45

Mizuho analyst Anthony Petrone maintains Staar Surgical (NASDAQ:STAA) with a Buy and lowers the price target from $50 to $45.

 piper-sandler-maintains-neutral-on-staar-surgical-lowers-price-target-to-33

Piper Sandler analyst Matt O'Brien maintains Staar Surgical (NASDAQ:STAA) with a Neutral and lowers the price target fro...

 staar-surgical-company-sees-fy24-adjusted-ebitda-of-36m-and-adjusted-ebitda-per-diluted-share-of-070

OutlookThe Company expects the following for fiscal year 2024:Net sales of $335 million to $340 million.Adjusted EBITDA of appr...

 staar-surgical-q4-eps-016-misses-017-estimate-sales-7627m-beat-7589m-estimate

Staar Surgical (NASDAQ:STAA) reported quarterly earnings of $0.16 per share which missed the analyst consensus estimate of $0.1...

 earnings-scheduled-for-february-26-2024

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.23 per share on...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION